Ducravog 30/5/10 mg (Pimasartan Potassium, Amlodipine, Rosuvastatin)

Adult dose

This medication is taken once daily, with or without food, accompanied by water. It is recommended to take it at the same time every day (e.g., morning). For Pimasartan/Amlodipine combinations: - 30/5 mg: Used for patients whose blood pressure is not adequately controlled with Pimasartan 30 mg monotherapy. - 30/10 mg: Used for patients who are not adequately controlled with Pimasartan 30 mg monotherapy or 30/5 mg.

Child dose

Safety and efficacy in pediatric and adolescent patients under 18 years of age have not been established.

This medication can cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be taken by individuals allergic to any ingredients in this medication or by those with specific liver diseases, kidney diseases, or muscle disorders. Patients with very low blood pressure or low blood volume, those with impaired kidney function, and elderly individuals should exercise caution when taking this medication and should have their conditions monitored frequently. If symptoms of muscle pain or weakness occur, consult a doctor immediately, and in severe cases, discontinue the medication. This medication can affect the liver and kidneys, so regular liver and kidney function tests should be conducted before and during treatment. There may be interactions with other medications, so if you are currently taking any other medications, you must inform your healthcare provider. Pregnant women or those planning to become pregnant should consult a doctor and use appropriate contraception. If breastfeeding, this medication can be transmitted through breast milk, so it is important to either discontinue breastfeeding or decide on use after consulting with a doctor. Overdose may lead to hypotension, cardiac arrhythmias, and require immediate medical attention. Dizziness may occur while driving or operating machinery, so caution is advised. Keep out of reach of children and do not transfer to other containers.

Serious side effects

Increased serum creatine phosphokinase (risk of myopathy), hypersensitivity reactions including angioedema (severe allergic reactions), urticaria (severe allergic reactions), thrombocytopenia, acute renal failure, chronic renal failure, pyelonephritis, jaundice (liver abnormalities), hepatitis, acute liver failure, Stevens-Johnson syndrome (severe skin reactions), eosinophilia and systemic symptoms associated with drug reaction with eosinophilia and systemic symptoms (DRESS) (severe skin reactions), transverse

Mild side effects

• Nausea
• peripheral edema
• nasopharyngitis
• influenza
• dizziness
• essential tremor
• rash
• itching
• headache
• asthenia

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and should be kept at a temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's efficacy and prevent degradation.

Appearance

Pale green pentagonal film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP*3]